Beyond Phase I: Expansion Cohort Trials Bring Efficiencies, Regulatory Challenges

First-in-human, expansion cohort trials are on the rise in oncology, but protocols for such studies can be highly problematic, lacking clear objectives, well-defined populations and independent oversight.